Aggressive B- Cell Lymphoma, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
著者 :
By Laurie Sehn, MD
This issue of Hematology/Oncology Clinics will cover aggressive B-Cell Lymphoma and articles to be included are: State of the art therapy for advanced stage DLBCL; DLBCL: Should limited stage patients be treated differently; Role of PET in DLBCL; Man
...view more
This issue of Hematology/Oncology Clinics will cover aggressive B-Cell Lymphoma and articles to be included are: State of the art therapy for advanced stage DLBCL; DLBCL: Should limited stage patients be treated differently; Role of PET in DLBCL; Management of relapsed DLBCL; The spectrum of double-hit lymphoma; Optimizing outcomes in primary mediastinal B cell lymphoma; The grey zone of unclassifiable lymphomas; as well as many more.
This issue of Hematology/Oncology Clinics will cover aggressive B-Cell Lymphoma and articles to be included are: State of the art therapy for advanced stage DLBCL; DLBCL: Should limited stage patients be treated differently; Role of PET in DLBCL; Management of relapsed DLBCL; The spectrum of double-hit lymphoma; Optimizing outcomes in primary mediastinal B cell lymphoma; The grey zone of unclassifiable lymphomas; as well as many more.
https://shop.elsevier.jp/aggressive-b-cell-lymphoma-an-issue-of-hematologyoncology-clinics-of-north-america-9780323477628.html302341Aggressive B- Cell Lymphoma, An Issue of Hematology/Oncology Clinics of North Americahttps://secure-ecsd.elsevier.com/covers/80/Tango2/large/9780323477628.jpg1390313903JPYInStock/Medicine & Surgery/Hematology/eBooks/Medicine/Hematology/eBooks/eBooks/Medicine/Hematology/Medicine/Hematology/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book443121443887245054622505466552550405259911580357859368005936822593682759368321418269243350884886536505455351451205259833579989258035265936799593680959368235936828This issue of Hematology/Oncology Clinics will cover aggressive B-Cell Lymphoma and articles to be included are: State of the art therapy for advanced stage DLBCL; DLBCL: Should limited stage patients be treated differently; Role of PET in DLBCL; Management of relapsed DLBCL; The spectrum of double-hit lymphoma; Optimizing outcomes in primary mediastinal B cell lymphoma; The grey zone of unclassifiable lymphomas; as well as many more. This issue of Hematology/Oncology Clinics will cover aggressive B-Cell Lymphoma and articles to be included are: State of the art therapy for advanced stage DLBCL; DLBCL: Should limited stage patients be treated differently; Role of PET in DLBCL; Management of relapsed DLBCL; The spectrum of double-hit lymphoma; Optimizing outcomes in primary mediastinal B cell lymphoma; The grey zone of unclassifiable lymphomas; as well as many more.00add-to-cart97803234776282016専門医By Laurie Sehn, MD20161E-BookElsevier02016/11/29IN STOCKBy <STRONG>Laurie Sehn</STRONG>, MD, BC Cancer AgencyE-BookE-BookThe Clinics: Internal Medicine米国いいえいいえいいえいいえいいえ選択してください選択してくださいいいえいいえ選択してください
